Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Genetics|May 5, 2012
Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus)Guy M L Perry, Keith W Nehrke, David A Bushinsky, et al.
American Journal of Nephrology|October 27, 2016
Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on HemodialysisDavid A Bushinsky, Patrick Rossignol, David M Spiegel, et al.
Journal of the American Society of Nephrology : JASN|February 22, 2003
The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal diseaseL Darryl Quarles, Donald J Sherrard, Stephen Adler, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2015
Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of HypercalciuriaNancy S Krieger, John R Asplin, Kevin K Frick, et al.
Kidney International|February 19, 2002
Calcium oxalate stone formation in genetic hypercalciuric stone-forming ratsDavid A Bushinsky, John R Asplin, Marc D Grynpas, et al.
Stem Cells (Dayton, Ohio)|November 22, 2012
Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injuryRebecca L Porter, Mary A Georger, Olga Bromberg, et al.
International Journal of Radiation Biology|July 23, 2019
Acute and late effects of combined internal and external radiation exposures on the hematopoietic systemLaura M Calvi, Benjamin J Frisch, Paul D Kingsley, et al.
Kidney International Reports|July 19, 2019
Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis PatientsJohn Cunningham, Geoffrey A Block, Glenn M Chertow, et al.
The American Journal of Medicine|November 29, 2017
Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS InhibitorsMatthew R Weir, David A Bushinsky, Wade W Benton, et al.
Pageof 19